Shukra Pharmaceuticals Limited
SHUKRAPHAR
Rank in Stocks
#13511
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Share Price
$0.87400294
Last synced: 2026-11-09
Market Cap
$384.22M
Change (1 day)
3.87%
Change (1 year)
85.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Category
Healthcare
EPS for Shukra Pharmaceuticals Limited (SHUKRAPHAR)
EPS as of June 2026 TTM: $0.01
According to Shukra Pharmaceuticals Limited's latest financial reports, its current EPS (TTM) is $0.01. At the end of 2025 the company had an EPS of 0.00, a decrease compared to its 2024 EPS of $0.05.
EPS history for Shukra Pharmaceuticals Limited from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.01 | -94.87% |
| 2025 | 0.00 | -94.87% |
| 2024 | $0.05 | -36.39% |
| 2023 | $0.08 | 2,315.15% |
| 2022 | 0.00 | 3,200.00% |
| 2021 | 0.00 | -83.33% |
| 2020 | 0.00 | -72.73% |
| 2019 | 0.00 | -15.38% |
| 2018 | 0.00 | -78.86% |
| 2017 | $0.01 | 1,950.00% |
| 2016 | 0.00 | -82.35% |
| 2015 | 0.00 | -116.59% |
| 2014 | $-0.02 | -95.50% |
| 2013 | $-0.46 | -1,476.74% |
| 2012 | $0.03 | 23.05% |
| 2011 | $0.03 | 135.96% |
| 2010 | $0.01 | 850.00% |
| 2009 | 0.00 | -140.00% |
| 2008 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | 20,764.20% |
US
|
|
| $1.93 | 23,737.04% |
SE
|
|
| $6.91 | 85,258.02% |
FR
|
|
| $0.02 | 140.74% |
HK
|
|
| $2.71 | 33,354.32% |
IT
|
Questions about Shukra Pharmaceuticals Limited's earnings per share (EPS)
What is Shukra Pharmaceuticals Limited's earnings per share (EPS)?
Shukra Pharmaceuticals Limited's earnings per share (EPS) over the last twelve months is $0.01, as of Jun 2026.
What was Shukra Pharmaceuticals Limited's earnings per share (EPS) in 2025?
In 2025, Shukra Pharmaceuticals Limited's earnings per share (EPS) was 0.00, compared with $0.05 in 2024.
How has Shukra Pharmaceuticals Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Shukra Pharmaceuticals Limited's earnings per share (EPS) was highest in 2023 ($0.08) and lowest in 2025 (0.00).
How does Shukra Pharmaceuticals Limited's earnings per share (EPS) compare with similar companies?
Shukra Pharmaceuticals Limited's earnings per share (EPS) ($0.01) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.